#COVAXIN : 1/n
Bharat Biotech invested in 2 vaccines:
CoroFlu in collaboration with FluGen Inc. and University of Wisconsin-Madison,
Iinactivated rabies vaccine vehicle for coronavirus proteins developed along with director of the Jefferson Vaccine Centre (JVC),Pennsylvania.
Bharat Biotech invested in 2 vaccines:
CoroFlu in collaboration with FluGen Inc. and University of Wisconsin-Madison,
Iinactivated rabies vaccine vehicle for coronavirus proteins developed along with director of the Jefferson Vaccine Centre (JVC),Pennsylvania.
2/n
On May 20, Bharat Biotech announced its collaboration with JVC as well as the license it had received to conduct clinical trials, and to produce and deliver vaccines in 80 countries excluding the US, Europe and Japan. On April 7, JVC announced a promising vaccine CORAVEX
On May 20, Bharat Biotech announced its collaboration with JVC as well as the license it had received to conduct clinical trials, and to produce and deliver vaccines in 80 countries excluding the US, Europe and Japan. On April 7, JVC announced a promising vaccine CORAVEX
3/n
Coravax uses an inactivated rabies vaccine to carry the spike protein of the novel coronavirus. The spike protein attaches to a host cell and causes an infection, so experts expected this vaccine to trigger a good immune response on the body’s part.
Coravax uses an inactivated rabies vaccine to carry the spike protein of the novel coronavirus. The spike protein attaches to a host cell and causes an infection, so experts expected this vaccine to trigger a good immune response on the body’s part.
4/n
This technology previously used against MERS and SARS
In early 2019, Bharat Biotech acquired Chiron Behring Vaccines Pvt. Ltd. from GlaxoSmithKline to produce “Chirorab” a 15 million units a year. So the company already has the ability to mass-produce this vaccine.
This technology previously used against MERS and SARS
In early 2019, Bharat Biotech acquired Chiron Behring Vaccines Pvt. Ltd. from GlaxoSmithKline to produce “Chirorab” a 15 million units a year. So the company already has the ability to mass-produce this vaccine.
5/n ...(last)
So basically this vaccine is a Corona Virus antigen spiked protein on a previously tested Rabies vaccine and is supposed to give promising results.
Conclusion: India is at the door step of tectonic changes on international arena !!
So basically this vaccine is a Corona Virus antigen spiked protein on a previously tested Rabies vaccine and is supposed to give promising results.
Conclusion: India is at the door step of tectonic changes on international arena !!
